Renal Injury during Long-Term Crizotinib Therapy

Crizotinib is highly effective against anaplastic lymphoma kinase-positive and c-ros oncogen1-positive non-small cell lung cancer. Renal dysfunction is associated with crizotinib therapy but the mechanism is unknown. Here, we report a case of anaplastic lymphoma kinase positive non-small cell lung c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Yasuma, Taro, Kobayashi, Tetsu, D’Alessandro-Gabazza, Corina N., Fujimoto, Hajime, Ito, Kentaro, Nishii, Yoichi, Nishihama, Kota, Baffour Tonto, Prince, Takeshita, Atsuro, Toda, Masaaki, Gabazza, Esteban C., Taguchi, Osamu, Yonemura, Shigenori, Hataji, Osamu
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2018
Matèries:
Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6213486/
https://ncbi.nlm.nih.gov/pubmed/30257437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19102902
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars